课题基金 / 基金详情

High Throughput Screening for Biased Agonists of the TSH Receptor that Activate the Beta-arrestin pathway

High Throughput Screening for Biased Agonists of the TSH Receptor that Activate the Beta-arrestin pathway
高通量筛选激活 β-抑制蛋白途径的 TSH 受体偏向激动剂
批准号：
10688945
负责人：
Juan Marugan
金额：
$42.54万
依托单位：
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/10688945
关键词：
AgonistArrestin Beta 1BiologyCell LineCollaborationsDiseaseEvaluationExtramural ActivitiesGoalsInformaticsMetabolicModelingOsteoporosisPathway interactionsPharmaceutical ChemistryPhenotypeProcessResearchResearch PersonnelSeriesSignal TransductionSynthesis ChemistryTestingThyrotropin ReceptorTranslationsUnited States National Institutes of HealthValidationWorkanalogassay developmentbasebeta-arrestindrug developmentdrug discoveryfollow-uphigh throughput screeninglead optimizationmouse modelnew technologynoveloverexpressionscreeningsmall moleculesmall molecule therapeuticstherapeutic developmenttool

项目摘要

项目成果

Juan Marugan的其他基金

相关文献

中文摘要
翻译
该项目的主要目标是开发一种有效的、选择性的小分子TSHR激动剂，具有偏倚的信号谱。
英文摘要
The main goal of this project is to develop a potent and selective small molecule TSHR agonist, with biased signaling profile. During this period, the most promising hits from high-throughput screening were identified and followed up with medicinal chemistry and several series of analogs were synthesized. Candidates with attractive activity profiles were pursued with medicinal chemistry to synthesize a series of new analogs, which were advanced for testing in a TSHR overexpressing cell line to determine beta-Arrestin 1 signaling. Pharamcokinetics of the most potent, selective and metabolically stable molecules were carried out. The optimized lead molecule is under evaluation in efficacy mouse models of osteoporosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small molecule agonists of the relaxin 1 receptor
Identification of Small Molecule that act on gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome
Kinetic High Throughput Screening for Agonists and Inhibitors of the TRPML1 Ion channel
HTS Assay for Identification of Compounds that Reduce PNC Prevalence